New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
04:55 EDTCFN, CFN, CFN, JAZZ, JAZZ, JAZZ, RMD, RMD, RMD, VNDA, VNDA, VNDA, XNPT, XNPT, XNPTAssociated Professional Sleep Societies to hold annual meeting
28th Annual SLEEP Meeting is being held in Minneapolis on May 31-June 4.
News For CFN;JAZZ;RMD;VNDA;XNPT From The Last 14 Days
Check below for free stories on CFN;JAZZ;RMD;VNDA;XNPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 15, 2014
08:11 EDTJAZZJazz Pharmaceuticals management meeting strengthens postive view, says Cowen
Subscribe for More Information
August 14, 2014
11:46 EDTVNDAOptions with decreasing implied volatility
Subscribe for More Information
August 13, 2014
10:33 EDTVNDAOptions with decreasing implied volatility
Options with decreasing implied volatility: RPTP ARWR ZU ICPT MNKD UBNT OLED RAX UVXY VNDA
August 12, 2014
15:53 EDTJAZZCanaccord to hold a conference
34th Annual Growth Conference to be held in Boston on August 13-14.
11:15 EDTVNDAOptions with decreasing implied volatility
Subscribe for More Information
07:33 EDTRMDQualcomm's subsidiary enters into collaboration to develop health solutions
Subscribe for More Information
August 11, 2014
11:28 EDTVNDAOptions with decreasing implied volatility
Options with decreasing implied volatility: GRPN MNKD UBNT OLED ZU RPTP SALE UNXL FEYE VNDA
06:03 EDTVNDAVanda pullback a buying opportunity, says Piper Jaffray
Piper Jaffray recommends using the post-earnings pullback in shares of Vanda Pharmaceuticals as a buying opportunity. Piper says Hetlioz is launching well and that it sees no reason to back off its bullish stance or $25 price target. The firm reiterates an Overweight rating on the name.
August 8, 2014
07:52 EDTCFNCareFusion price target raised to $49 from $42 at Stifel
Subscribe for More Information
August 7, 2014
16:24 EDTCFNCareFusion announces new $750M share repurchase authorization
Subscribe for More Information
16:23 EDTCFNCareFusion see mid-single-digit revenue growth through FY17
Subscribe for More Information
16:22 EDTCFNCareFusion sees FY15 adjusted EPS $2.60-$2.75, consensus $2.68
Subscribe for More Information
16:21 EDTCFNCareFusion reports Q4 adjusted EPS 79c, consensus 72c
Reports Q4 revenue $1.12B, consensus $1.04B.
15:33 EDTCFN Notable companies reporting after market close
Subscribe for More Information
15:31 EDTCFNNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include CBS (CBS), consensus 72c; Consolidated Edison (ED), consensus 54c; Monster Beverage (MNST), consensus 75c; News Corporation (NWSA), consensus 3c; NVIDIA (NVDA), consensus 20c; Computer Sciences (CSC), consensus 94c; CareFusion (CFN), consensus 72c;DeVry Education (DV), consensus 67c; Salix Pharmaceuticals (SLXP), consensus $1.72; Federal Realty (FRT), consensus $1.21; SolarCity (SCTY), consensus (99c); Medivation (MDVN), consensus 24c; Sprouts Farmers Market (SFM), consensus 18c; Alnylam Pharmaceuticals (ALNY), consensus (56c); Lions Gate (LGF), consensus 17c; Mercadolibre (MELI), consensus 56c; Post Holdings (POST), consensus 27c; Assured Guaranty (AGO), consensus 35c; Great Plains Energy (GXP), consensus 41c; Air Lease (AL), consensus 52c; Ubiquiti Networks (UBNT), consensus 51c; SemGroup (SEMG), consensus 35c.
07:10 EDTVNDAVanda Pharmaceuticals sees 2014 operating expenses $11.0M-$12.0M
Subscribe for More Information
07:10 EDTVNDAVanda Pharmaceuticals sees 2014 operating expenses $11.0M-$12.0M
Subscribe for More Information
07:09 EDTVNDAVanda Pharmaceuticals reports Q2 EPS (64c), consensus (73c)
Subscribe for More Information
August 6, 2014
16:47 EDTXNPTXenoPort reports Q2 EPS (31c), consensus (33c)
Subscribe for More Information
09:21 EDTJAZZJazz Pharmaceuticals thesis remains intact, says Cowen
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use